首页 / 院系成果 / 成果详情页

On-Treatment ALT Normalization Has No Statistical Significant Impact on Liver Stiffness Regression in Chinese Chronic Hepatitis B Patients with Advanced Fibrosis or Cirrhosis Receiving Tenofovir Disoproxil Fumarate Therapy 期刊论文 会议论文

编号：

347de6a3-14a2-4d82-b7ab-7558add6a09a
作者：

Wei, Lai^[1];Shang, Jia^[2];Xie, Qing^[3];Jia, Zhansheng^[4];Gao, Pujun^[5];Shi, Junping^[6];Chen, Xinyue^[7];Wang, Jiefei^[8];Xu, Min^[9];Zhang, Liaoyun^[10];Zhao, Yingren^[11];Wang, Maorong^[12];Mao, Qing^[13];Zhao, Wei^[14];Zhang, Zong^[15];Jia, Jidong^[16];Tang, Hong^[17];Zhang, Jiming(张继明)^[18]Zheng, Xin^[19];Xiong, Cui^[20];Zhu, Mingfen^[21];
语种：

English
期刊：

HEPATOLOGY ISSN：0270-9139 2018 年 68 卷 (229A - 230A) ; OCT
收录：
推荐引用方式
GB/T 7714：

Wei Lai,Shang Jia,Xie Qing, et al. On-Treatment ALT Normalization Has No Statistical Significant Impact on Liver Stiffness Regression in Chinese Chronic Hepatitis B Patients with Advanced Fibrosis or Cirrhosis Receiving Tenofovir Disoproxil Fumarate Therapy [J].HEPATOLOGY,2018,68:229A-230A.
APA：

Wei Lai,Shang Jia,Xie Qing,Jia Zhansheng,&Zhu Mingfen.(2018).On-Treatment ALT Normalization Has No Statistical Significant Impact on Liver Stiffness Regression in Chinese Chronic Hepatitis B Patients with Advanced Fibrosis or Cirrhosis Receiving Tenofovir Disoproxil Fumarate Therapy .HEPATOLOGY,68:229A-230A.
MLA：

Wei Lai, et al. "On-Treatment ALT Normalization Has No Statistical Significant Impact on Liver Stiffness Regression in Chinese Chronic Hepatitis B Patients with Advanced Fibrosis or Cirrhosis Receiving Tenofovir Disoproxil Fumarate Therapy" .HEPATOLOGY 68(2018):229A-230A.

浏览次数：5  下载次数：0

浏览次数：5

下载次数：0

打印次数：0

On-Treatment ALT Normalization Has No Statistical Significant Impact on Liver Stiffness Regression in Chinese Chronic Hepatitis B Patients with Advanced Fibrosis or Cirrhosis Receiving Tenofovir Disoproxil Fumarate Therapy 期刊论文会议论文